On the Record · Evolent Health

Evolent Health acquisitions, on the record

The businesses Evolent Health bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.

Deals its annual reports describe

Business	Deal	When	Value
Vital Decisions Word for word“On October 1, 2021, we consummated the acquisition of Vital Decisions for $46.5 million in cash and the issuance of 1.8 million shares of Class A common stock.” 10-K for 2023	acquisition	October 1, 2021	$46.5 million in cash and the issuance of 1.8 million shares of Class A common stock
IPG Word for word“On August 1, 2022, we consummated the acquisition of IPG for $256.5 million in cash and the issuance of 3.7 million shares of Class A common stock.” 10-K for 2023	acquisition	August 1, 2022	$256.5 million in cash and the issuance of 3.7 million shares of Class A common stock
NIA Word for word“On January 20, 2023, we consummated the acquisition of NIA for $387.8 million in cash consideration, which was financed in part with $265.0 million in debt borrowed from affiliates of Ares Capital Corporation (“Ares”) and the proceeds from the sale of an aggregate 175,000 shares of the Company’s Series A Preferred Stock, resulting in gross proceeds of $168.0 million, and stock consideration of 8.5 million shares of Class A common stock issued to the seller.” 10-K for 2023	acquisition	January 20, 2023	$387.8 million in cash consideration
Machinify, Inc. (certain assets and Machinify Auth license) Word for word“The acquisition consideration was $28.5 million which included $19.5 million of cash, $11.0 million which was paid upon closing and $8.5 million which was paid on November 1, 2024, as well as an earn-out consisting of additional consideration of up to $12.5 million payable in cash or shares of the Company’s Class A common stock at the election of the Company in the second quarter of 2025.” 10-K for 2024	acquisition	—	$28.5 million
Machinify Word for word“Cash flows used in investing activities of $62.9 million in the year ended December 31, 2024 were primarily attributable to cash paid for asset acquisitions and business combinations of $30.7 million which is inclusive of $19.5 million for the purchase of Machinify and $3.0 million for investment in future equity notes, and $24.9 million of investments in internal-use software and purchases of property and equipment.” 10-K for 2025	acquisition	—	$19.5 million
New Century Health Word for word“The foundation for our specialty care management services solution was our acquisition in 2018 of New Century Health, a national leader in managing specialty care for Medicare members under performance-based and technology and services arrangements.” 10-K for 2025	acquisition	in 2018	—

As filedReported in the company's financial data (XBRL), each linked to its filing
Fiscal year ended	Goodwill from acquisitions
2016-12-31	$178.3 million
2017-12-31	$0
2018-12-31	$140.2 million
2019-12-31	$3.4 million
2021-12-31	$77.3 million
2022-12-31	$296.6 million
2023-12-31	$395.2 million
2024-12-31	$20.8 million
2025-12-31	$0

Deal filings since 2016

2025-08-21 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2025-06-20 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2025-02-04 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2024-12-11 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2023-12-11 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2023-01-23 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2023-01-23 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
2022-11-17 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2022-08-02 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2022-06-29 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2021-08-04 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2021-01-13 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2020-12-22 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2020-09-04 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
2020-08-25 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2020-07-17 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2019-12-31 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2019-12-31 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
2019-05-28 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2018-10-23 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2018-10-02 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2018-10-02 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
2018-09-12 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2017-08-14 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2017-06-28 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2017-05-19 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2017-03-31 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2016-12-05 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2016-10-03 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2016-10-03 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
2016-09-14 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2016-07-14 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement

Read from Evolent Health’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-25. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.